Alcon (ALC) Cash from Investing Activities (2009 - 2026)
Alcon (ALC) recorded quarterly Cash from Investing Activities of -$218.0 million in Q1 2026, up 27.33% quarter-over-quarter from -$300.0 million in Q4 2025.
Alcon (ALC) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Alcon's Cash from Investing Activities history runs 11 years deep, the most recent figure standing at -$218.0 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$218.0 million; the TTM figure through Mar 2026 stood at -$984.0 million (changed N/A YoY), while the FY2025 annual figure was -$1.3 billion, down 15.17% from the prior year.
- Cash from Investing Activities was -$218.0 million for Q1 2026 at Alcon, up from -$300.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$133.0 million in Q2 2024 to a low of -$852.0 million in Q4 2022.
- Historically, Cash from Investing Activities has averaged -$319.4 million across 5 years, with a median of -$275.5 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities plunged 360.31% in 2022, then soared 74.3% in 2023.
- A 5-year view of Cash from Investing Activities shows it stood at -$852.0 million in 2022, then jumped by 56.1% to -$374.0 million in 2023, then rose by 10.96% to -$333.0 million in 2024, then climbed by 9.91% to -$300.0 million in 2025, then rose by 27.33% to -$218.0 million in 2026.
- The last three Cash from Investing Activities figures came in at -$218.0 million (Q1 2026), -$300.0 million (Q4 2025), and -$312.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Alcon | 25,681.50 | -1.66 Bn | 1.53 Bn | -218.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -218.00 Mn |
| Mar 31, 2026 | -218.00 Mn |
| Dec 31, 2025 | -300.00 Mn |
| Dec 31, 2025 | -300.00 Mn |
| Sep 30, 2025 | -312.00 Mn |
| Sep 30, 2025 | -312.00 Mn |
| Jun 30, 2025 | -154.00 Mn |
| Jun 30, 2025 | -154.00 Mn |
| Dec 31, 2024 | -333.00 Mn |
| Dec 31, 2024 | -333.00 Mn |
| Sep 30, 2024 | -483.00 Mn |
| Sep 30, 2024 | -483.00 Mn |
| Jun 30, 2024 | -133.00 Mn |
| Jun 30, 2024 | -133.00 Mn |
| Mar 31, 2024 | -218.00 Mn |
| Mar 31, 2024 | -218.00 Mn |
| Dec 31, 2023 | -374.00 Mn |
| Dec 31, 2023 | -374.00 Mn |
| Sep 30, 2023 | -152.00 Mn |
| Sep 30, 2023 | -152.00 Mn |